High intratumoral plasma cells content in primary prostate cancer defines a subset of tumors with potential susceptibility to immune-based treatments

Document Details

Document Type
Pub Defense Publication
Publication Date
May 14, 2022
Source ID
10.1038/s41391-022-00547-0

Entities

People

  • Adam B. Weiner
  • Antonina Mitrofanova
  • Christina Y. Yu
  • Edward M. Schaeffer
  • Elai Davicioni
  • Mitali Kini
  • Tamara L Lotan
  • Yang Liu

Organizations

  • American Cancer Society
  • National Institutes of Health
  • Prostate Cancer Foundation
  • United States Department of Defense